| Makale Türü | Özgün Makale |
| Makale Alt Türü | SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale |
| Dergi Adı | Chemistry and Biodiversity |
| Dergi ISSN | 1612-1872 Wos Dergi Scopus Dergi |
| Dergi Tarandığı Indeksler | SCI-Expanded |
| Dergi Grubu | Q3 |
| Makale Dili | Türkçe |
| Basım Tarihi | 01-2023 |
| Cilt No | 20 |
| Sayı | 1 |
| Sayfalar | 1 / 12 |
| DOI Numarası | 10.1002/cbdv.202200872 |
| Makale Linki | http://dx.doi.org/10.1002/cbdv.202200872 |
| Özet |
| Breast cancer is known as the most common type of invasive cancer in women. It is well-known that phenolic compounds play an important role in the treatment of this disease. This study hypothesized that isoeugenol based two polyphenolic compounds 1 and 2 exerts its anti-proliferative effects through the induction of apoptosis and cell migration arrest on human breast cancer cell. Based on this hypothesis, the study aimed to investigate the anti-proliferative, anti-migrative effects of these compounds and their possible basic molecular mechanisms of action in MCF-7 cell lines. As a result, isoeugenol-based compounds 1 and 2 showed anti-proliferative, anti-apoptotic and anti-migrative effects in MCF-7 breast cancer cells. This result was supported by molecular analyzes and it was determined that there were changes in the expression of some gene regions involved in apoptosis and migration. Additionally, it was a remarkable result that cell viability inhibition did not occur in healthy breast tissue cells and no cytotoxic effect was observed. The existence of such a differentiation between cancer cells and healthy cells significantly increases the potential of these compounds to be used as chemotherapeutic drug active ingredients without side effects. |
| Anahtar Kelimeler |
| breast cancer | cell proliferation | apoptosis | cell migration | phenolic compounds |
| Dergi Adı | CHEMISTRY & BIODIVERSITY |
| Yayıncı | Wiley-Blackwell |
| Açık Erişim | Hayır |
| ISSN | 1612-1872 |
| E-ISSN | 1612-1880 |
| CiteScore | 3,5 |
| SJR | 0,425 |
| SNIP | 0,700 |